Nemec Sarah bought BOLT
June 5, 2026 · Form 4 insider transaction
Nemec Sarah bought 509 shares of Bolt Biotherapeutics, Inc. at $3.88 per share, a transaction worth $2.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 108 days after the transaction.
Direction
Acquired (buy-side)
Shares
509
Price
$3.88
Total value
$2.0K
InsiderNemec Sarah
RoleOfficer
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 5, 2026
Filing dateSeptember 21, 2026
Shares owned after1,924
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).